Table 1.
Antibacterial activity of the metabolites against selected clinical and typed pathogens.
| Metabolites |
||||
|---|---|---|---|---|
| A | B | C | D | |
| Clinical isolates | ||||
| Escherichia coli (ECO 050102) | + (17 mm) | +(29 mm) | +(30 mm) | +(29 mm) |
| Salmonella sp. (SAL PS049) | +(19 mm) | +(38 mm) | +(27 mm) | +(24 mm) |
| Salmonella sp (STY AAA 0026) | +(20 mm) | +(19 mm) | +(21 mm) | –– |
| Escherichia coli (ECO 050335) | +(14 mm) | +(25 mm) | +(26 mm) | +(26 mm) |
| Salmonella sp (STY AAA 0039) | +(16 mm) | +(21 mm) | +(19 mm) | +(29 mm) |
| Typed isolates | ||||
| Escherichia coli (ATCC 25922) | +(24 mm) | +(26 mm) | +(26 mm) | +(24mm) |
| Salmonella typhi (ATCC 20971) | +(20 mm) | +(27 mm) | +(28 mm) | +(20 mm) |
| Klebsiella pneumonia | +(28 mm) | +(29 mm) | +(32 mm) | +(30 mm) |
| Staphylococcus aureus (ATCC 6538) | +(35 mm) | +(31 mm) | +(33 mm) | +(31 mm) |
‘+’ and ‘-’ indicate sensitive and resistant, respectively. Values in parenthesis represent the zones of inhibition on the test bacteria. A, B, C and D represent metabolites produced by B. proteolyticus, B. thuringensis, B. cereus and B, subtilis, respectively.